VRX

Valeant (VRX): Cantor Sings the Praises of Comeback in Motion

Cantor’s Louise Chen shares a bullish take on VRX following its first quarter print and plans for a name change to Bausch Health Companies.

Julie Lamb — May 8, 2018, 4:57 PM EDT

All Eyes on Valeant (VRX) 1Q:18 Earnings This Morning

H.C.

Julie Lamb — May 8, 2018, 6:32 AM EDT

RBC Capital Bets Valeant’s Safe 2018 Guide Gets Boosted Come Q2 Earnings

RBC Capital’s Douglas Miehm anticipates Wall Street could be discounting a first quarter guidance lift considering latest VRX share price performance.

Julie Lamb — May 2, 2018, 10:00 AM EDT

Valeant Pharmaceuticals (VRX) Draws a Price Target Lift from Deutsche Bank; Here’s Why

Deutsche Bank’s Gregg Gilbert now angles for 22% in return potential for VRX shares following good litigation news for largest drug Xifaxan.

Julie Lamb — May 1, 2018, 12:18 PM EDT

Valeant Pharmaceuticals’ ׁ(VRX) Division Ortho Dermatologics Announces Publication of Pivotal Efficacy and Safety Data for Psoriasis Treatment DUOBRII in the JAAD

Ortho Dermatologics, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), announced that the Journal of the American Academy of Dermatology (JAAD) published for the first …

Corey Williams — April 9, 2018, 8:00 AM EDT

Why This Analyst No Longer Makes a Bearish Call on Valeant Pharmaceuticals (VRX)

Mizuho’s Irina Rivkind Koffler has gotten more upbeat on the VRX name, but her raised expectations watch for 6% in loss potential for the stock.

Julie Lamb — April 6, 2018, 9:11 AM EDT

Valeant Pharmaceuticals Intl Inc (VRX) Subsidary Salix Wins Over Support of IBS Awareness Month Founders for New National Campaign

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) wholly owned subsidiary Salix is fostering a new two-way conversation between health care providers and irritable bowel syndrome …

Corey Williams — April 3, 2018, 10:03 AM EDT